[ad_1]
A Brazilian volunteer who participated in the vaccine clinics developed by the University of Oxford and the AstraZeneca laboratory died. According to the Brazilian newspaper Or Balloon, the man died due to complications from Covid-19, last Thursday. The company did not say whether this patient had received a dose of the vaccine or a placebo.
The Brazilian newspaper reports that the National Health Surveillance Agency (Anvisa) was formally informed of the death of the patient this Monday, which it explained to the Balloon that the case is under evaluation, but that the investigation has not been suspended and that the International Security Evaluation Committee has already received all the data of the case, also giving the go-ahead to continue with the tests.
The volunteer who died was a 28-year-old doctor who, since March, was on the front line of patient care in Covid-19, in intensive care units and in emergencies.
It is not yet clear whether the patient had received a dose of the vaccine if they had received a test placebo. In an answer quoted by BalloonAnvisa stated that “based on the ethical confidentiality commitments provided in the protocol, the regulatory bodies involved receive partial data related to the research carried out by this committee, for which they suggested continuing with the study.”
So far, around 8,000 volunteers have been “vaccinated” in Brazil and more than 20,000 people around the world under this project.
Studies for this vaccine had already been stopped when a British patient had suspected transverse sclerosis, and then resumed when it was found that this disease was not related in any way to the vaccine.
According to the doctor’s friends, the young man was in good health and had no other known diseases that could hinder the fight against the disease caused by the new coronavirus.
The doctor will have received a dose of the AstraZeneca and Oxford vaccine / placebo by the end of July. He fell ill in September and died on October 15.
[ad_2]
